Visteon (NASDAQ:VC – Get Free Report) had its price target reduced by stock analysts at Royal Bank of Canada from $127.00 to $100.00 in a report released on Wednesday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Royal Bank of Canada’s price target indicates a potential upside of 11.87% from the company’s current price.
Several other research analysts have also recently commented on the stock. StockNews.com cut shares of Visteon from a “buy” rating to a “hold” rating in a research report on Sunday, November 3rd. Wells Fargo & Company raised their target price on Visteon from $119.00 to $124.00 and gave the company an “overweight” rating in a research report on Wednesday. Finally, Barclays reduced their price target on Visteon from $140.00 to $115.00 and set an “overweight” rating for the company in a research report on Wednesday, January 22nd. Six investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $123.77.
Read Our Latest Analysis on VC
Visteon Price Performance
Visteon (NASDAQ:VC – Get Free Report) last issued its quarterly earnings data on Tuesday, February 18th. The company reported $4.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.97 by $2.47. Visteon had a return on equity of 46.19% and a net margin of 13.22%. The firm had revenue of $939.00 million during the quarter, compared to the consensus estimate of $954.17 million. As a group, sell-side analysts anticipate that Visteon will post 8.27 EPS for the current year.
Hedge Funds Weigh In On Visteon
A number of institutional investors have recently bought and sold shares of the business. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in shares of Visteon by 24.0% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 80,916 shares of the company’s stock worth $7,179,000 after purchasing an additional 15,666 shares during the period. Voloridge Investment Management LLC increased its stake in Visteon by 23.4% during the 4th quarter. Voloridge Investment Management LLC now owns 229,114 shares of the company’s stock worth $20,327,000 after acquiring an additional 43,464 shares during the period. Teza Capital Management LLC acquired a new position in shares of Visteon in the 4th quarter valued at approximately $233,000. Systematic Financial Management LP lifted its holdings in shares of Visteon by 3.4% during the 4th quarter. Systematic Financial Management LP now owns 268,495 shares of the company’s stock worth $23,821,000 after acquiring an additional 8,854 shares during the period. Finally, ProShare Advisors LLC increased its stake in Visteon by 41.2% in the fourth quarter. ProShare Advisors LLC now owns 8,978 shares of the company’s stock valued at $797,000 after acquiring an additional 2,618 shares during the last quarter. Institutional investors and hedge funds own 99.71% of the company’s stock.
Visteon Company Profile
Visteon Corporation, an automotive technology company, designs, manufactures, and sells automotive electronics and connected car solutions for vehicle manufacturers worldwide. The company provides instrument clusters, including analog gauge clusters for 2-D and 3-D display-based devices; information displays that integrate a range of user interface technologies and graphics management capabilities, such as active privacy, TrueColor enhancement, local dimming, cameras, optics, haptic feedback, and light effects; and infotainment and connected car solutions, including scalable Android infotainment for seamless connectivity, as well as onboard artificial intelligence-based voice assistants with natural language understanding.
Read More
- Five stocks we like better than Visteon
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
- What is a Bond Market Holiday? How to Invest and Trade
- Solid Biosciences Soars 32% on Trial Data: 189% Upside from Here?
- Are Penny Stocks a Good Fit for Your Portfolio?
- Up Nearly 1000%, Can AppLovin Keep Delivering for Investors?
Receive News & Ratings for Visteon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Visteon and related companies with MarketBeat.com's FREE daily email newsletter.